More General News
View Older Stories View Newer Stories-
Walt Disney top pick at Morgan Stanley, experiences segment to drive growth
-
Dow Inc. shares rise after Evercore ISI upgrades to 'outperform'
-
Sam Altman-backed Oklo signs power agreement with data center operator
-
Return of NASA astronauts from space station further delayed until late March
-
Mastercard unveils new $12B stock buyback program; hikes quarterly dividend
-
US Senator Warren says Trump needs to hold Musk to ethics standards
-
Morgan Stanley starts Hims&Hers at ‘overweight,’ on strong revenue growth
-
Shoals Technologies upgraded by Morgan Stanley on upbeat 2025 outlook
-
Rosenblatt starts MongoDB at buy, neutral on Rubrik
-
MicroStrategy's Nasdaq-100 entry attracts nearly $11 million of retail inflows
-
Tesla castigates German union over attempt to oust works council head
-
Starbucks workers' union authorizes potential US strike
-
Morgan Stanley downgrades CommScope to 'underweight' on limited upside
-
Barclays downgrades WEX, Marqeta on growth concerns
-
Alcon Top Pick for 2025 at Needham, added to Conviction List
-
AI startup Databricks hits $62 billion valuation in record VC round
-
Stellantis Italian plants to increase output from 2026, Europe's chief says
-
Morgan Stanley bullish on machinery industry, upgrades stocks
-
Bitcoin mining stocks rise after getting a new bull on Street
-
US retail sales showcase economy's enduring strength
-
Biden Agrees to Record $15B Loan to PG&E Corp. (PCG) - reports
-
Fiat owner Stellantis launches upbeat plan to boost manufacturing in Italy
-
Tesla set to ride Trump tailwinds over next four years: Mizuho
-
IT hardware spending to improve in 2025
-
BofA upgrades Ambarella to ‘neutral’
-
US congressional negotiators aim to fund government through March 14, source says
-
Why US stock market gains will continue – UBS
-
Loop Capital upgrades Netflix to 'buy' on subscriber growth, content pipeline
-
Jefferies Upgrades Bristol Myers Squibb to ‘buy’ on drug Cobenfy
-
Stifel downgrades Biogen on slow Alzheimer’s drug launch, uncertainty ahead
-
JPMorgan upgrades Okta to 'overweight' on improved growth prospects
-
Lockheed forms subsidiary to help defense companies adopt AI
-
Wells Fargo cuts Nike price target on weak demand
-
Morgan Stanley upgrades AT&T amid broadband competition; downgrades Comcast
-
US factory activity slumps further in December as tariffs loom
-
Jana urges Lamb Weston board to fix company or put itself up for sale
-
This is the top oil stock to watch for 2025, Jefferies says
-
Robotaxi Usage to Remain Immaterial Until at Least 2027, Jefferies says
-
Ford down after Jefferies downgrade stock to ‘underperform’
-
Regional lenders Berkshire Hills Bancorp, Brookline strike $1.1 billion merger deal
-
Arm CEO downplays ambitions to make its own chip in Qualcomm case
-
Honeywell considers spinning off aerospace business amid Elliott's breakup push
-
Exclusive-Procter & Gamble to disclose more details about wood-pulp audits, investors say
-
J&J accuses divisions of Cigna of helping drain its drug copay funds, WSJ reports
-
Trump calls for end to daylight saving time
-
Fed rate view in focus as robust stocks year draws to close
-
Brokerages downgrade gene editing company Editas to 'hold', shares slump 23%
-
Goldman starts coverage on beauty stocks, Efl Beauty shares up 4%
-
Exclusive-Databricks nears record $9.5 billion VC raise, eyes extra $4.5 billion debt
-
Mizuho downgrades RingCentral on subscription growth concerns, shares down 7%
